| Current supplement Archive Acta Ophthalmologica Polonica |
1-2/2004
vol. 106 abstract:
Original paper
The effectiveness of latanoprost for the treatment of pediatric glaucoma
Beata Urban
1
,
Alina Bakunowicz-Łazarczyk
1
,
Małgorzata Mrugacz
1
,
Monika Oziębło-Kupczyk
1
KLINIKA OCZNA 2004, Supl. 1-2: S243–S244
Online publish date: 2022/12/30
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Latanoprost is a prostaglandin F2α analog that reduces intraocular pressure by 20-40% in adults with open-angle glaucoma. The efficacy and safety of this drug in children has not been widely reported. In our study we evaluated the effect of latanoprost in 14 children aged 12-18 years (mean 15 years): 10 patients with glaucoma juvenile (I group); 2 patients with secondary glaucoma because of uveitis recidivans and 2 patients with aniridia and albinismus (II group). In the I group the average IOP decrement was 9 mmHg or 36,5% (range 29-44%). In the II group the average IOP decrement was 6,5 mmHg or 23,5% (range 11-33%). In one child with aniridia after one year of treatment IOL rose again to 26 mmHg and antiglaucomatous surgery was necessary. Ocular side effects in children of latanoprost are mild.
keywords:
latanoprost, children, glaucoma |
